Crossmark

Analysis of the short-to-intermediate-term efficacy of autologous costochondral transplantation in treatment for Hepple V osteochondral lesion of talus

Crossref DOI link: https://doi.org/10.1186/s40001-025-03053-w

Published Online: 2025-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Jiazheng

Zhang, Jieyuan

Fu, Shaolin

Li, Xueqian

Wang, Cheng

Wu, Chenglin

Zhang, Shutao

Ma, Xin

Shi, Zhongmin
Funding

Funding for this research was provided by:

Science and Technology Commission of Shanghai Municipality (24Y32800100)

Shanghai Municipal Commission of Economy and Informatization (23SHS03600)
License Information

Text and Data Mining valid from 2025-08-21

Version of Record valid from 2025-08-21
More Information

Article History

Received: 27 May 2025

Accepted: 11 August 2025

First Online: 21 August 2025

Declarations

:

: The study was approved by the Ethics Committee of Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University (2023–039). The confidentiality of patient information was protected. The study was conducted in compliance with the Helsinki Declaration.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below